PRESS RELEASE published on 04/28/2023 at 08:00, 1 year 6 months ago Epigenomics AG publishes financial results for fiscal year 2022
PRESS RELEASE published on 04/12/2023 at 20:05, 1 year 7 months ago Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
PRESS RELEASE published on 04/12/2023 at 19:56, 1 year 7 months ago EQS-Adhoc: Epigenomics AG: Changes in the Management
PRESS RELEASE published on 03/20/2023 at 20:19, 1 year 8 months ago EQS-Adhoc: Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
PRESS RELEASE published on 03/10/2023 at 09:37, 1 year 8 months ago Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
PRESS RELEASE published on 02/15/2023 at 11:18, 1 year 9 months ago Epigenomics decides to restructure to minimize costs
PRESS RELEASE published on 02/15/2023 at 11:13, 1 year 9 months ago EQS-Adhoc: Epigenomics resolves on restructuring to minimize costs
PRESS RELEASE published on 01/27/2023 at 18:08, 1 year 9 months ago Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski
PRESS RELEASE published on 01/27/2023 at 14:16, 1 year 9 months ago EQS-Adhoc: Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski
Published on 11/21/2024 at 13:30, 23 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 23 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 53 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 53 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 53 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 37 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 55 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 33 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
